NCBIO Annual Meeting

Save the date for the 27th NCBIO Annual Meeting to be held Tuesday, Oct. 5. The hybrid event will feature a keynote by Jude Samulski, Ph.D., president, chief scientific officer and co-founder of AskBio, and will offer both live and virtual content.

LEARN MORE

NCBIO Members Save Big with BIO Business Solutions

BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.

LEARN MORE

NC Biotech Honors Sam Taylor

NC Biotech President and CEO Doug Edgeton presents Nancy Reed with a proclamation honoring her late husband and NCBIO president, Sam Taylor.

NCBIO, the North Carolina Biosciences Organization

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.

Member Benefits

A variety of discount programs are available to members.

Partners and Resources

NCBIO works with national organizations and connects with many North Carolina life science resources.

Recent Blog Posts

Government price fixing for U.S. medicines will cost lives, jobs, innovation

May 13, 2021

Legislation like H.R. 3 that fixes prices for prescription medicines would limit patients’ access to new treatments while doing nothing to lower prices at the pharmacy counter.

Vaccine patent waiver breaks faith with American companies, stifles innovation

May 13, 2021

NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19…

BIO: Why the TRIPS waiver wouldn’t work

April 20, 2021

BIO President and CEO Dr. Michelle McMurry-Heath sent a letter April 19 to U.S. Trade Representative Ambassador Katherine Tai to explain why the WTO’s proposed “TRIPS waiver” would have global health and economic consequences as the pandemic rages on.